发明名称 |
Mucin production inhibitor |
摘要 |
To provide a drug useful for prevention or treatment of respiratory diseases accompanying hyper-secretion of mucus, the drug normalizing physiological functions of the respiratory tract by preventing over-production of mucin from the respiratory tract epithelium. A mucin production inhibitor comprising, as an active ingredient, a benzimidazole derivative represented by formula (1): (wherein A represents a triazole group; R<SUP>1 </SUP>and R<SUP>2 </SUP>may be identical to or different from each other, and each represents an aliphatic hydrocarbon group which may have an alicyclic hydrocarbon group, or an alicyclic hydrocarbon group; R<SUP>3 </SUP>represents a hydrogen atom or a substituent; and R<SUP>4 </SUP>represents a hydrogen atom or a protective group for the nitrogen atom) or a pharmacologically acceptable salt thereof.
|
申请公布号 |
US2005222234(A1) |
申请公布日期 |
2005.10.06 |
申请号 |
US20050065567 |
申请日期 |
2005.02.25 |
申请人 |
TAIHO PHARMACEUTICAL CO., LTD. |
发明人 |
SASAKI EIJI;KINIWA MAMORU |
分类号 |
A61K31/4196;(IPC1-7):A61K31/419 |
主分类号 |
A61K31/4196 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|